Log in

NASDAQ:ALBOAlbireo Pharma SEC Filings & 10K Form

$25.95
-0.26 (-0.99 %)
(As of 07/3/2020 12:54 PM ET)
Add
Compare
Today's Range
$24.85
Now: $25.95
$26.66
50-Day Range
$25.03
MA: $26.73
$29.92
52-Week Range
$11.26
Now: $25.95
$32.38
Volume109,998 shs
Average Volume94,634 shs
Market Capitalization$388.73 million
P/E RatioN/A
Dividend YieldN/A
Beta1.9

SEC Filings

Albireo Pharma (NASDAQ:ALBO) SEC Filings

DateFilerForm TypeView
06/26/2020
4:02 PM
Albireo Pharma (Issuer)
Stephenson Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
5:59 PM
Albireo Pharma (Issuer)
Chiswell David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
5:53 PM
Albireo Pharma (Issuer)
SCOON DAVEY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
5:24 PM
Albireo Pharma (Issuer)
Okey Stephanie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
5:20 PM
Albireo Pharma (Issuer)
Klibanski Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
5:09 PM
Albireo Pharma (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
5:06 PM
Albireo Pharma (Issuer)
Gutch Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
3:19 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2020
6:37 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2020
11:15 PM
Albireo Pharma (Filer)
Form EFFECT
05/07/2020
7:06 AM
Albireo Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2020
6:37 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2020
7:57 PM
Albireo Pharma (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2020
10:12 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2020
9:33 AM
Albireo Pharma (Subject)
Satter Muneer A (Filed by)
Form SC 13G/A
02/04/2020
7:00 AM
Albireo Pharma (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2020
4:16 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2020
3:03 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2020
3:02 PM
Albireo Pharma (Filer)
Form 424B5
01/29/2020
3:44 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2020
3:43 PM
Albireo Pharma (Filer)
Form 424B5
01/23/2020
7:10 PM
Albireo Pharma (Issuer)
Graham Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2020
7:09 PM
Albireo Pharma (Issuer)
Carter Martha J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2020
6:49 PM
Albireo Pharma (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2020
6:45 PM
Albireo Pharma (Issuer)
Cooper Ronald Harold Wilfred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2020
6:42 PM
Albireo Pharma (Issuer)
Stephenson Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2020
6:32 PM
Albireo Pharma (Issuer)
Mattsson Jan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2020
6:28 PM
Albireo Pharma (Issuer)
Horn Patrick Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2020
6:22 PM
Albireo Pharma (Issuer)
Duncan Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
3:18 PM
Albireo Pharma (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2019
8:06 AM
Albireo Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
6:38 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2019
3:51 PM
Albireo Pharma (Issuer)
Graham Michelle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
3:46 PM
Albireo Pharma (Issuer)
Graham Michelle (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/08/2019
8:17 AM
Albireo Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2019
7:29 AM
Albireo Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
7:07 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2019
4:21 PM
Albireo Pharma (Issuer)
SCOON DAVEY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
4:00 PM
Albireo Pharma (Issuer)
Chiswell David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
3:56 PM
Albireo Pharma (Issuer)
Okey Stephanie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
3:53 PM
Albireo Pharma (Issuer)
Klibanski Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
3:49 PM
Albireo Pharma (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2019
3:47 PM
Albireo Pharma (Issuer)
Gutch Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
3:01 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2019
12:37 PM
Albireo Pharma (Subject)
FEDERATED INVESTORS INC /PA/ (Filed by)
Form SC 13G
05/09/2019
9:09 AM
Albireo Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
6:47 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2019
3:02 PM
Albireo Pharma (Filer)
Form 424B3
04/30/2019
11:15 PM
Albireo Pharma (Filer)
Form EFFECT
04/25/2019
3:05 PM
Albireo Pharma (Filer)
Form DEFA14A
04/25/2019
3:03 PM
Albireo Pharma (Filer)
Form DEF 14A
04/03/2019
5:02 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2019
4:34 PM
Albireo Pharma (Issuer)
Stephenson Pamela (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2019
4:29 PM
Albireo Pharma (Issuer)
Stephenson Pamela (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/13/2019
1:39 PM
Albireo Pharma (Subject)
Phase4 Partners Ltd (Filed by)
Form SC 13D/A
03/07/2019
7:00 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2019
4:28 PM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2019
4:27 PM
Albireo Pharma (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/06/2019
4:22 PM
Albireo Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2019
6:53 AM
Albireo Pharma (Subject)
ArrowMark Colorado Holdings LLC (Filed by)
Form SC 13G
02/13/2019
10:04 AM
Albireo Pharma (Subject)
Satter Muneer A (Filed by)
Form SC 13G/A
01/24/2019
5:48 PM
Albireo Pharma (Issuer)
Horn Patrick Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
5:45 PM
Albireo Pharma (Issuer)
Duncan Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
5:28 PM
Albireo Pharma (Issuer)
Mattsson Jan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
5:25 PM
Albireo Pharma (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
5:21 PM
Albireo Pharma (Issuer)
Cooper Ronald Harold Wilfred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2019
5:17 PM
Albireo Pharma (Issuer)
Carter Martha J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2018
3:12 PM
Albireo Pharma (Issuer)
Cooper Ronald Harold Wilfred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2018
6:16 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2018
4:01 PM
Albireo Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/08/2018
3:14 PM
Albireo Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/12/2018
3:36 PM
Albireo Pharma (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/12/2018
3:28 PM
Albireo Pharma (Issuer)
Harford Simon N.R. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/10/2018
7:38 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2018
3:26 PM
Albireo Pharma (Issuer)
Cooper Ronald Harold Wilfred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2018
3:04 PM
Albireo Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/09/2018
2:06 PM
Albireo Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2018
3:14 PM
Albireo Pharma (Issuer)
Horn Patrick Taylor (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2018
3:09 PM
Albireo Pharma (Issuer)
Horn Patrick Taylor (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2018
6:48 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/25/2018
7:39 AM
Albireo Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/06/2018
3:17 PM
Albireo Pharma (Issuer)
BROWN JULIA R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
4:40 PM
Albireo Pharma (Issuer)
SCOON DAVEY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
4:36 PM
Albireo Pharma (Issuer)
Okey Stephanie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
4:33 PM
Albireo Pharma (Issuer)
Klibanski Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
4:05 PM
Albireo Pharma (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
4:02 PM
Albireo Pharma (Issuer)
Gutch Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
3:58 PM
Albireo Pharma (Issuer)
Chiswell David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
6:49 PM
Albireo Pharma (Issuer)
Mattsson Jan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
3:37 PM
Albireo Pharma (Issuer)
Soni Paresh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
3:26 PM
Albireo Pharma (Issuer)
Mattsson Jan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
3:24 PM
Albireo Pharma (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
3:22 PM
Albireo Pharma (Issuer)
Cooper Ronald Harold Wilfred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
3:21 PM
Albireo Pharma (Issuer)
Carter Martha J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
3:19 PM
Albireo Pharma (Issuer)
Okey Stephanie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
3:18 PM
Albireo Pharma (Issuer)
Okey Stephanie (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/11/2018
3:16 PM
Albireo Pharma (Issuer)
Klibanski Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
3:14 PM
Albireo Pharma (Issuer)
Klibanski Anne (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/11/2018
3:12 PM
Albireo Pharma (Issuer)
Duncan Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
3:09 PM
Albireo Pharma (Issuer)
Duncan Jason (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
This page was last updated on 7/3/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.